Overall Technical outlook

Price Summary

On 2025-12-11, Mankind Pharma Limited's shares started at 2148.9, peaked at 2177.1, bottomed out at 2130.0, and ended 0.83% higher at 2166.8, with 143464 shares traded.
Over the past year, the stock's highest price was 2998.4, and its lowest was 2148.9.
The future price of MANKIND is projected to range from 2150.0 to 3260.0, with an average expected price of 2683.1765, according to 17 analysts.

Technicals


Aroon: The Aroon indicator shows a continuation of the bearish trend, with Aroon Down holding steady at the 100 level. This ongoing downward pressure requires further exploration with additional indicators to understand its broader implications.
MANKIND aroon 994abd
Aroon chart for Mankind Pharma Limited


Bol. Bands: In the most recent move, the price has crossed above the lower Bollinger Band after previously being below it. This upward shift may indicate a recovery from oversold conditions, suggesting that the market could be transitioning out of its bearish phase. The crossover above the lower band could be a sign of a potential trend reversal or a slowdown in the downward momentum.
MANKIND bbands 994abd
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a resistance level that could impede any upward movement. This resistance indicates that the market may continue to face bearish pressure, with limited potential for breaking higher.
MANKIND psar 994abd
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The Stochastic K-line has moved below both the D-line and the 20 level, reflecting a mildly bearish signal for MANKIND. This suggests that the market might encounter some downward pressure, but the overall bearish tone is moderate. Traders should remain observant for any further indications of a downturn.
MANKIND stoch 994abd
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The 20-50-100 period moving averages suggest a bullish trend, though the weakening slopes of the shorter-term averages raise concerns about a potential reversal. While the overall momentum is still upward, the indications from the faster averages suggest that the trend might be nearing its end, warranting caution.
MANKIND trippleSMA 994abd
Tripple SMA chart for Mankind Pharma Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.